Home › Lung Diseases › Michigan
Lung Diseases clinical trials in Michigan
17 studies for Lung Diseases are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Revive Research Institute, Inc., Southfield
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Revival Research Institute, LLC, Dearborn
- Henry Ford St. John Hospital, Grosse Pointe Woods
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- North Ingalls Building, Ann Arbor
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Michigan, Ann Arbor
- The Cancer & Hematology Centers, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Michigan, Ann Arbor
- Henry Ford Health, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Ann Arbor
- Clinical Research Site, Detroit
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Detroit
- Research Site, Royal Oak
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Jul 17, 2026 · NCT06177717Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761Supporting Evidence-based Responses to Emotional Needs in Emphysema
- Henry Ford Health System, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06600126A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.